323 related articles for article (PubMed ID: 19443794)
21. Is acute stroke treatment heading towards a more endovascular approach?
Menon BK; Demchuk AM
Lancet Neurol; 2009 Sep; 8(9):778-9. PubMed ID: 19647487
[No Abstract] [Full Text] [Related]
22. Intravenous or intra-arterial thrombolysis?: it's time to find the right approach for the right patient.
Mattle HP
Stroke; 2007 Jul; 38(7):2038-40. PubMed ID: 17540964
[No Abstract] [Full Text] [Related]
23. Estimated weight is not a reliable measure for dosing tissue plasminogen activator for thrombolysis in acute ischaemic stroke.
Gill D; Halsey L; Kalkat H; Patel S; Kar A
Int J Stroke; 2016 Feb; 11(2):NP25-6. PubMed ID: 26783320
[No Abstract] [Full Text] [Related]
24. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
Sharma VK; Teoh HL; Chan BP
J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
[No Abstract] [Full Text] [Related]
25. [Thrombolytic therapy: formation and current practice of intravenous thrombolysis in acute ischemic stroke].
Iavorskaia VA; Flomin IuV; D'olog NV; Grebeniuk AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():13-27. PubMed ID: 16447549
[TBL] [Abstract][Full Text] [Related]
26. Intravenous thrombolysis.
Nguyen TH; Truong AT; Ngo MB; Bui CT; Dinh QV; Doan TC; Nguyen LT; Phan TC; Phan MV; Nguyen TV; Le TV
Int J Stroke; 2010 Dec; 5(6):516. PubMed ID: 21050414
[No Abstract] [Full Text] [Related]
27. Effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in older adults.
Dirks M; Koudstaal PJ; Dippel DW; Niessen LW; van Wijngaarden JD; Franke CL; van Oostenbrugge RJ
J Am Geriatr Soc; 2011 Nov; 59(11):2169-71. PubMed ID: 22098036
[No Abstract] [Full Text] [Related]
28. Editorial comment--More than one way to lyse a clot.
Kasner SE
Stroke; 2004 Apr; 35(4):911-2. PubMed ID: 15044811
[No Abstract] [Full Text] [Related]
29. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
[TBL] [Abstract][Full Text] [Related]
30. Thrombolysis in acute ischemic stroke.
Lang W; Domanovits H; Görzer H; Germann P; Gatterbauer E; Segall B
Acta Anaesthesiol Scand Suppl; 1997; 111():34-7. PubMed ID: 9420947
[No Abstract] [Full Text] [Related]
31. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
[TBL] [Abstract][Full Text] [Related]
32. Current acute stroke trials and their potential impact on the therapeutic time window.
Schellinger PD; Köhrmann M
Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
[TBL] [Abstract][Full Text] [Related]
33. Endovascular (intraarterial) treatment of acute ischemic stroke: efficacy not supported by clinical trials.
Powers WJ
South Med J; 2014 Feb; 107(2):101-6. PubMed ID: 24926676
[TBL] [Abstract][Full Text] [Related]
34. When is enough enough?
Donnan GA; Davis SM
Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042
[No Abstract] [Full Text] [Related]
35. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
Jahan R; Vinuela F
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
[TBL] [Abstract][Full Text] [Related]
36. Repeated MR-based intravenous thrombolysis in a patient with short interval stroke recurrences.
Nicoli F; Faivre A; Squarcioni C; Combaz X; Girard N
J Neuroradiol; 2011 Oct; 38(4):256-8. PubMed ID: 21093916
[No Abstract] [Full Text] [Related]
37. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
Rollins G
Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
[No Abstract] [Full Text] [Related]
38. Further randomized controlled trials of tissue plasminogen activator within 3 hours are required.
Lindley RI
Stroke; 2001 Nov; 32(11):2708-9. PubMed ID: 11692040
[No Abstract] [Full Text] [Related]
39. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
[TBL] [Abstract][Full Text] [Related]
40. IV tissue plasminogen activator for stroke in the community: what we know and don't know 10 years after FDA approval.
Furlan AJ
Stroke; 2006 Feb; 37(2):281. PubMed ID: 16397163
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
